r/SNDL • u/Love2Garden860 • 11h ago
Discussion SNDL: The Earnings Potential Hidden Within Its U.S. Investments
this is worth a read, so I copied and pasted since Reddit would not allow the link to the article
Summary
SNDL Inc. trades at a substantial discount to book and tangible book value, despite significant underlying asset value and U.S. cannabis exposure.
SNDL's investments in Parallel and Skymint, via SunStream Bancorp, offer material unrecognized earnings potential, with combined 2025 revenue of CAD 265 million.
Recent restructuring and increased ownership in Parallel position SNDL to benefit from U.S. cannabis market integration and regulatory tailwinds.
I rate SNDL a Speculative Buy due to undervaluation, improving operations, and asymmetric upside versus already-reflected downside risk.
Editor's note: Seeking Alpha is proud to welcome Daniel Klim as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.
Investment Thesis
SNDL Inc. (SNDL) presents an interesting investment opportunity because of the gap between its current valuation and the potential earnings of its underlying assets. The company operates a considerable Canadian liquor and cannabis business, but what I find particularly interesting is its investment portfolio.
Through SunStream Bancorp, SNDL maintains investments in several U.S. cannabis businesses whose revenue is not directly consolidated into its financial statements. Two of these investments, Parallel and Skymint, generated approximately CAD 265 million in combined revenue during 2025, according to SNDL's investor presentation. With the recent restructuring of Parallel and SNDL's increased indirect equity interest to approximately 92%, I believe the company is in a better position to benefit from these investments going forward.
What interests me is the possibility that the company's current financial statements are not giving investors a complete picture of its future earnings potential. This is especially important given the substantial discount to book value at which the company currently trades.
SNDL's Existing Operations
SNDL operates through four segments: liquor retail, cannabis retail, cannabis operations and investments. For this analysis, I will use the most recent quarterly results alongside the trailing twelve months ending September 30, 2026. This is important because SNDL experiences considerable seasonality, with Q1 generally being the weakest quarter and Q4 the strongest.
Liquor Retail
According to SNDL's Q3 2026 results, the company operates 165 liquor retail locations through brands including Ace Liquor, Liquor Depot, and Wine and Beyond. During the quarter, the segment generated CAD 134.8 million in revenue and CAD 6.0 million in operating income, while trailing twelve-month revenue reached approximately CAD 522.4 million.
Although same-store sales declined 6.0% during the quarter, gross margins improved to a record 27.0%. I view liquor retail as a relatively stable and profitable part of the business. It isn't where I expect most of the future growth to come from, but it does provide an established source of earnings.
Cannabis Retail
SNDL operates 193 cannabis retail locations, including franchises, mainly through Value Buds and Spiritleaf. During Q3 2026, the segment generated CAD 85.6 million in revenue and CAD 5.2 million in operating income. Over the trailing twelve months, revenue reached approximately CAD 329.4 million, based on the company's latest financial results.
Despite a 3.8% decline in same-store sales, the segment continued to perform relatively well, supported by new locations and improving margins. I also think the company's experience operating such a large cannabis retail network could become useful when considering the potential integration of its U.S. investments.
Cannabis Operations
Cannabis operations remain the company's weakest business. During Q3 2026, revenue declined 27.7% year over year to CAD 27.0 million, while trailing twelve-month revenue reached approximately CAD 125.8 million. The segment recorded an operating loss of CAD 64.7 million during the quarter, including approximately CAD 52 million in goodwill impairment. Even excluding impairment and restructuring costs, the segment recorded an adjusted operating loss of CAD 11.4 million.
In my opinion, much of this quarter's reported loss was one-off. The majority came from the goodwill impairment, while additional losses were tied to inventory adjustments and the company's decision to exit the unprofitable dried flower category. This has naturally led to a decline in revenue and additional pressure on operating profitability as the company changes its focus. Going forward, I expect these changes to improve the segment's profitability, although the adjusted operating loss demonstrates that there are still underlying issues to address.
Consolidated Performance
Over the trailing twelve months ending September 30, 2026, SNDL generated approximately CAD 922.2 million in consolidated revenue, compared with CAD 946.4 million during the full calendar year 2025, using its 2025 annual results and the latest nine-month figures.
During Q3 2026, the company recorded an operating loss of CAD 48.3 million, largely because of the impairment mentioned earlier. However, adjusted operating income reached CAD 5.2 million, compared with an adjusted operating loss of CAD 9.5 million during Q3 2025.
While I find this improvement encouraging, it should be noted that CAD 7.9 million of operating income came from the investment segment, including CAD 6.9 million in equity-accounted profits mainly related to an increase in Parallel's valuation. This means the company's Canadian operations still have considerable room for improvement, which is something I expect management's recent changes to address.
The Investment Portfolio
SNDL holds a 50% ownership interest in SunStream Bancorp, a joint venture through which it has invested in several U.S. cannabis businesses. Because SunStream is accounted for using the equity method, SNDL recognizes its share of the investment's results rather than directly including the underlying businesses' revenue and expenses.
As of September 30, 2026, SNDL's cannabis-related investment portfolio had a carrying value of approximately CAD 485.2 million, of which CAD 467.7 million related to SunStream.
This is where I think the company becomes particularly interesting. Although these investments are already represented on the balance sheet, their underlying operating businesses are not directly reflected in consolidated revenue. As a result, the earning potential of these assets is not immediately apparent when looking at SNDL's income statement.
The two investments I want to focus on are Parallel and Skymint.
Parallel
Parallel originally received a USD 150 million secured loan through SunStream in May 2021. Following financial difficulties, the company underwent a restructuring that was completed on July 27, 2026,eliminating approximately USD 842 million of legacy debt obligations.
During Q3 2026, SNDL participated in a rights offering that increased its indirect equity interest in Parallel from approximately 67% to 92%, as detailed in the company's third-quarter results. To me, this is one of the more important developments in SNDL's investment portfolio, as the company now has substantial economic exposure to an established U.S. cannabis operator.
Parallel operates 56 retail and pickup locations across Florida, Texas, and Massachusetts, alongside three cultivation and manufacturing facilities. According to SNDL's investor presentations, the business generated approximately CAD 212 million in revenue during 2025, down from CAD 257 million in 2024. While the decline is concerning, Parallel continues to maintain approximately USD 150 million in annualized revenue, equivalent to roughly CAD 213 million.
For comparison, that represents approximately 23% of SNDL's current trailing twelve-month revenue.
SNDL is working toward a structure that would allow it to directly consolidate qualifying U.S. medical cannabis operations while maintaining regulatory and Nasdaq compliance. This would mainly concern Parallel's medical operations in Florida and Texas, while adult-use operations, including those in Massachusetts, would remain outside the proposed initial consolidation.
Although this could result in a notable increase in reported revenue, what interests me more is the potential earnings contribution. The company would also have greater influence over how the eligible operations are managed and how capital is allocated.
Unfortunately, Parallel's current profitability is not sufficiently disclosed. However, we can use its existing revenue to understand what different operating margins could mean.
At USD 150 million in annual revenue, a 5% operating margin would produce USD 7.5 million in operating income. At 10%, this would increase to USD 15 million, while a 15% margin would produce USD 22.5 million.
These figures are before taxes, financing costs, and ownership adjustments, so they should not be treated as profits attributable directly to SNDL. However, given SNDL's intention to bring these assets under its direct management, I think it's important to understand the full scope of what could eventually become part of the company's operations. This would represent a significant opportunity for SNDL to expand directly into the U.S. cannabis market, with Parallel potentially serving as its entry point.
Skymint
Skymint is another investment that I believe deserves consideration, although I am considerably less confident in its near-term potential.
The business operates in Michigan through brands including Skymint Premium Cannabis, North Cannabis, and PotCo. Like Parallel, Skymint encountered financial difficulties following financing provided through SunStream and eventually entered receivership proceedings in 2023.
During 2024, Skymint generated approximately CAD 88 million in revenue, which declined to CAD 53 million in 2025. The company also reduced its retail footprint from 19 locations to 17 while moving away from cultivation and manufacturing.
Although the decline in revenue is substantial, I think the change in business structure is worth considering. By focusing primarily on retail, Skymint may be able to reduce some of the fixed costs associated with cultivation. Whether this has actually improved profitability remains unclear.
Using its 2025 revenue of CAD 53 million, a hypothetical operating margin of 5% would produce approximately CAD 2.7 million in operating income. At 10%, this would increase to CAD 5.3 million, while a 15% margin would produce approximately CAD 8.0 million.
Skymint's investment carrying value within SunStream declined from CAD 83.1 million at the end of 2025 to CAD 68.1 million at September 30, 2026. Its restructuring also remains subject to legal proceedings, and its exposure to Michigan's adult-use market creates additional complications.
For these reasons, I view Skymint more as an additional opportunity than something I would base the investment thesis around. However, I still think it represents the possibility of further U.S. expansion through SunStream. Should the restructuring prove successful, Skymint could provide further evidence that SNDL's investment strategy is capable of producing meaningful opportunities beyond its existing Canadian operations.
Combining the Opportunities
Looking at Parallel and Skymint together gives a better idea of the potential importance of SNDL's investment portfolio.
During 2025, the two businesses generated approximately CAD 265 million in combined revenue. For comparison, SNDL generated CAD 946.4 million over the same period. Including both businesses hypothetically would bring combined revenue to approximately CAD 1.21 billion.
Of course, this is not necessarily the amount SNDL will be able to consolidate. The current ownership structure and regulatory restrictions mean some operations may remain outside the company's financial statements. However, I think the comparison helps demonstrate the scale of the investments.
What I find more important is their potential earnings. Using the combined CAD 265 million in revenue, an operating margin of 5% would produce approximately CAD 13.3 million in operating income. At 10%, this would increase to CAD 26.5 million, while a 15% margin would produce CAD 39.8 million.
These figures represent the potential operating income of the underlying businesses, not necessarily the amount SNDL shareholders would receive. Still, the numbers become quite interesting when compared with the company's current financial performance.
In my previous analysis, I considered the possibility of SNDL eventually generating between CAD 1.3 billion and CAD 1.5 billion in annual revenue, with net profit margins of approximately 5% to 7%. This would produce somewhere between CAD 65 million and CAD 105 million in annual net earnings.
Uncertainty remains. Achieving these figures would require improvement in the Canadian businesses, profitable U.S. operations, and additional growth. However, I continue to believe it is a reasonable scenario to examine when considering the company's longer-term potential, especially with the company's current efforts to improve profitability, even at the cost of revenue.
With SNDL's market capitalization at approximately CAD 482 million, CAD 65 million in net earnings would represent a hypothetical P/E ratio of approximately 7.4. At CAD 105 million, the ratio would fall to approximately 4.6.
While these are hypothetical earnings rather than what the company currently generates, I think they demonstrate the potential earnings power of SNDL should it continue improving its operations. This also leads me to believe that some of the company's recent financial difficulties may be more a result of its ongoing restructuring than evidence that the business cannot become profitable. Whether that proves to be the case will depend on how much profitability improves over the coming quarters.
U.S. Regulatory Developments
Another factor worth considering is the changing regulatory environment in the United States.
On April 23, 2026, the U.S. Department of Justice announced a final order moving qualifying medical cannabis activities into Schedule III of the Controlled Substances Act, as explained in the U.S. Treasury and IRS announcement.
This is particularly important because Section 280E restricts ordinary business expense deductions for businesses dealing in Schedule I or II controlled substances. Qualifying medical cannabis operations could therefore benefit from more favourable tax treatment, depending on the applicable rules and further guidance.
I believe this could be particularly beneficial to Parallel because SNDL's proposed integration focuses on medical cannabis operations.
Unlike consolidation, which mainly changes how the business is reported, lower taxes could directly improve earnings and cash generation. However, the benefits should not be assumed to apply to all of Parallel's operations, particularly those involved in adult-use cannabis.
Valuation
SNDL's financial position is another reason I find the company interesting. According to its Q3 2026 financial statements, SNDL reported CAD 132.5 million in unrestricted cash and CAD 485.2 million in cannabis-related investments, giving it approximately CAD 617.7 million in combined cash and investments. Total shareholders' equity stood at approximately CAD 1.01 billion.
Using its November 4 closing price of CAD 1.98 and approximately 243.3 million shares outstanding, SNDL had a market capitalization of roughly CAD 482 million. This represents a price-to-book ratio of approximately 0.48. Even after removing goodwill and intangible assets, tangible book value remained approximately CAD 875.5 million, giving the company a price-to-tangible-book ratio of 0.55.
I find this discount substantial, particularly when compared with other cannabis companies. Using their latest available financial statements and November 4 share prices, Cronos Group (CRON) traded at approximately 1.29 times tangible book value, while Village Farms International(VFF) traded at approximately 1.44 times. These calculations use closing prices of USD 3.51 for Cronos and USD 2.93 for Village Farms. Both companies therefore trade at considerably higher valuations relative to their tangible assets.
However, I don't believe this difference can be attributed entirely to market mispricing. Cronos maintains a particularly strong balance sheet, while Village Farms has demonstrated stronger recent profitability. SNDL, meanwhile, continues to face losses within its cannabis operations and considerable uncertainty surrounding SunStream. For another comparison, High Tide reported CAD 8.7 million in operating income during its third fiscal quarter of 2026, demonstrating the importance of profitability when comparing cannabis businesses.
One of my main concerns when valuing SNDL is the uncertainty surrounding SunStream's carrying value of CAD 467.7 million. To account for this, consider a hypothetical 50% reduction in its value. This would reduce SNDL's tangible book value to approximately CAD 641.7 million, leaving the company trading at roughly 0.75 times adjusted tangible book value. Even under this assumption, SNDL would continue trading at a discount to its reported net tangible assets, although this does not guarantee those assets could be realized at their carrying values.
I also believe the company's potential earnings deserve consideration. As discussed earlier, I see a scenario in which SNDL could eventually generate CAD 65 million to CAD 105 million in annual net earnings. At the November 4 market capitalization, this would represent hypothetical P/E ratios between approximately 7.4 and 4.6. These figures depend on substantial improvements in profitability, but they illustrate why I find the company's longer-term earnings potential interesting.
In my opinion, the current discount reflects genuine concerns surrounding SNDL's profitability and investment portfolio. However, when comparing its valuation with peers and considering potential improvements in Canadian operations alongside the integration of Parallel, I believe the market may be assigning too little value to its opportunities for growth. Should management successfully improve profitability and realize value from SunStream, the current discount could become increasingly difficult to justify.
Capital Allocation and Risks
SNDL's capital allocation is another aspect worth examining.
During Q3 2026, the company reported approximately CAD 20 million in free cash flow under its non-IFRS definition. However, CAD 10.6 million came from the unwinding of a captive insurance arrangement, meaning a substantial portion was nonrecurring.
Despite this positive free cash flow, the company's cash balance declined by approximately CAD 50.7 million. This was largely the result of CAD 60.8 million in strategic U.S. investments and CAD 10 million in share repurchases.
I don't necessarily consider the decline in cash a problem since much of it was used to increase the company's exposure to Parallel. However, the money being invested needs to eventually produce a return.
SNDL has also been actively reducing its outstanding share count. Through October 22, the company had repurchased approximately 23.1 million shares during 2026. Management has also proposed a substantial issuer bid of up to CAD 50 million, subject to approvals.
Given the current discount to book value, I believe the repurchases could be beneficial to shareholders. Nevertheless, I would prefer that the company maintain enough cash to support its existing businesses and take advantage of future opportunities.
As for the risks, the biggest concern is that the investments fail to generate the profits I expect. Parallel has already experienced considerable difficulties and has required substantial additional capital, while Skymint remains subject to litigation and uncertainty surrounding its restructuring.
There is also no guarantee that SNDL will be able to consolidate the eligible U.S. operations, and its Canadian cannabis operations continue to lose money.
If Parallel fails to improve profitability, SunStream requires further substantial write-downs, or the Canadian operations continue consuming cash without improvement, I would have to reconsider the thesis.
Conclusion
SNDL presents an interesting investment opportunity because of the difference between its current market valuation and the potential earnings of its underlying assets.
Through SunStream, the company maintains substantial economic exposure to U.S. cannabis businesses whose operating revenue is not currently represented in its consolidated financial statements. Parallel and Skymint together generated CAD 265 million in revenue during 2025, while their restructuring and potential future integration provide opportunities for stronger financial performance.
At approximately 0.48 times reported book value and 0.55 times tangible book value, SNDL trades at a considerable discount to its reported assets. Some of that discount is understandable given the uncertainty surrounding its investments and the weaknesses of its existing operations. However, given the company's current direction, I would argue that these weaknesses might also represent some of its largest opportunities for improving profitability.
I believe the current valuation does not properly reflect the company's financial position. SNDL has demonstrated an ability to generate cash while maintaining ample opportunities for growth through its investment portfolio, even if the nature of that portfolio makes its potential more difficult to recognize. These two factors together make me believe there is considerable room for the company's earnings and share price to improve.
Furthermore, given the substantial discount to its reported assets, I believe much of the downside risk is already reflected in the current share price. Although the stock could certainly decline further, especially if its investments fail to perform as expected, I believe the potential upside considerably outweighs that risk, leaving room for a significant upswing. For these reasons, I would give SNDL a Speculative Buy rating.
This article was written by
Daniel Klim